- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2613EUR$2,750USD£2,240GBP
From €2613EUR$2,750USD£2,240GBP
- Report
- September 2022
- 159 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,218GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,218GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,218GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,218GBP
- Report
- April 2023
- 84 Pages
Europe
From €4180EUR$4,400USD£3,584GBP
- Report
- September 2021
- 110 Pages
Global
From €4275EUR$4,500USD£3,666GBP
- Report
- March 2021
- 101 Pages
Global
€20901EUR$22,000USD£17,922GBP
- Report
- March 2021
- 75 Pages
Global
€20901EUR$22,000USD£17,922GBP
- Report
- July 2019
- 498 Pages
Global
€20901EUR$22,000USD£17,922GBP
- Report
- March 2019
- 39 Pages
Global
€9500EUR$10,000USD£8,146GBP
- Report
- March 2019
- 62 Pages
Global
€9500EUR$10,000USD£8,146GBP
- Report
- March 2019
- 33 Pages
Global
€9500EUR$10,000USD£8,146GBP
- Report
- April 2018
- 38 Pages
Global
From €9500EUR$10,000USD£8,146GBP
- Report
- April 2018
- 34 Pages
Global
From €9500EUR$10,000USD£8,146GBP
The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more